In Brief: FDA drug approval application form
This article was originally published in The Tan Sheet
FDA drug approval application form: FDA announces availability of revised form FDA 356h for use by applicants submitting all NDAs and ANDA/AADAs in the July 9 Federal Register. The revised form replaces the FDA 356h for NDAs, ANDAs/AADAs revised in October 1993. FDA says it "believes that a harmonized application format will allow companies to provide higher quality submissions, reduce preparation time, expedite review by FDA and easily adapt to electronic submissions when that becomes possible and practical." Applicants can use the form now; its use will be required beginning Jan. 8...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC